Skip to content

Protara Therapeutics, Inc.: filings

Every Protara Therapeutics, Inc. annual and quarterly report in the SEC record with the published financial measures it tagged, 48 filings, each linked to its SEC index.

Filings with published measures

Each page shows what one filing reported, as tagged in that filing, with the periods it covered. Later filings can restate a value; the company overview shows the latest-filed value per period.

FormFiledFiscal periodMeasuresFactsSEC accession
10-Q2026-08-11fiscal Q2 2026371050001213900-26-087508
10-Q2026-05-13fiscal Q1 202637760001213900-26-055463
10-K2026-03-10fiscal FY 202542840001213900-26-025433
10-Q2025-11-10fiscal Q3 2025371090001213900-25-107881
10-Q2025-08-11fiscal Q2 2025371050001213900-25-073942
10-Q2025-05-08fiscal Q1 202537760001213900-25-040811
10-K2025-03-05fiscal FY 202441830001213900-25-020368
10-Q2024-11-12fiscal Q3 2024371070001213900-24-096252
10-Q2024-08-06fiscal Q2 2024371020001213900-24-065380
10-Q2024-05-02fiscal Q1 202438780001213900-24-038757
10-K2024-03-13fiscal FY 202343870001213900-24-021982
10-Q2023-11-03fiscal Q3 2023391130001213900-23-083013
10-Q2023-08-03fiscal Q2 2023381050001213900-23-062782
10-Q2023-05-04fiscal Q1 202337780001213900-23-036113
10-K2023-03-08fiscal FY 202241840001213900-23-018373
10-Q2022-11-03fiscal Q3 2022371110001213900-22-069010
10-Q2022-08-09fiscal Q2 2022381080001213900-22-045922
10-Q2022-05-05fiscal Q1 202237780001213900-22-024238
10-K2022-03-09fiscal FY 202142820001213900-22-011208
10-Q2021-11-04fiscal Q3 202135960001213900-21-056770
10-Q2021-08-05fiscal Q2 202136930001213900-21-040535
10-Q2021-05-06fiscal Q1 202137730001213900-21-024773
10-K2021-03-11fiscal FY 202037690001213900-21-014709
10-Q2020-11-12fiscal Q3 202033840001213900-20-036343
10-Q2020-07-31fiscal Q2 202033790001213900-20-019642
10-Q2020-05-13fiscal Q1 202032600001213900-20-011893
10-K2020-03-20fiscal FY 201930560001171843-20-001860
10-Q2019-10-31fiscal Q3 201932910001171843-19-007045
10-Q2019-08-07fiscal Q2 201934910001171843-19-005225
10-Q2019-05-08fiscal Q1 201932650001171843-19-003097
10-K2019-03-13fiscal FY 201832880001171843-19-001687
10-Q2018-11-07fiscal Q3 201831800001171843-18-007677
10-Q2018-08-07fiscal Q2 201831800001171843-18-005792
10-Q2018-05-09fiscal Q1 201831610001171843-18-003700
10-K2018-03-14fiscal FY 201733930001171843-18-001934
10-Q2017-11-07fiscal Q3 201732820001171843-17-006678
10-Q2017-08-07fiscal Q2 201729760001171843-17-004786
10-Q2017-05-10fiscal Q1 201728570001171843-17-002898
10-K2017-03-16fiscal FY 201631930001171843-17-001555
10-Q2016-11-07fiscal Q3 201628760001171843-16-012987
10-Q2016-08-08fiscal Q2 201628760001171843-16-011564
10-Q2016-05-09fiscal Q1 201628570001171843-16-009802
10-K2016-03-14fiscal FY 2015331070001171843-16-008541
10-Q2015-11-12fiscal Q3 201530800001171843-15-006275
10-Q2015-08-13fiscal Q2 201530800001171843-15-004685
10-Q2015-05-13fiscal Q1 201527520001171843-15-002808
10-K2015-03-20fiscal FY 2014321110001171843-15-001528
10-Q2014-11-25fiscal Q3 201431840001171843-14-005683

Inspect the source

Entity
Protara Therapeutics, Inc. / CIK 0001359931
Captured
2026-09-20T07:55:59.662Z
SEC response SHA-256
73c5c8e9513bdc55c707e83d9669fc2bd4dbb1b11805f8d13591997b9e86c1c4

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001359931.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))